Viewing Study NCT06059066


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-31 @ 11:23 AM
Study NCT ID: NCT06059066
Status: COMPLETED
Last Update Posted: 2025-05-09
First Post: 2023-09-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
Sponsor: The Methodist Hospital Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurogenic Bladder View
None Lower Urinary Tract Symptoms View
None Overactive Bladder View
None Neuro: Neurogenic Bladder View
None Neurogenic Detrusor Overactivity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neurogenic bladder View
None Lower urinary tract symptoms View
None Neurogenic detrusor overactivity View
None Onabotulinum toxinA View